NPI registry status
Active
2026 NPPES data Plastic and Reconstructive Surgery Physician NPI 1134134406 MD
Verify on CMS → Emily McLaughlin, MD
Plastic and Reconstructive Surgery Physician in Fort Worth, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 2,421 in Plastic and Reconstructive Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
137
Medicare Part D claims · 37 beneficiaries · Plastic and Reconstructive Surgery Physician avg: 92
Industry payments
$515.76
8 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Emily McLaughlin, MD filed 137 Medicare Part D claims in 2024 as a Plastic and Reconstructive Surgery Physician in Fort Worth, Texas.
- 137
- Part D claims, 2024
- $515.76
- industry payments (Sunshine Act)
- ≥34th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Emily McLaughlin, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1134134406), first enumerated 07/29/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 137 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$515.76 in reported industry payments (8 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Emily McLaughlin, MD's individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1134134406 · Plastic and Reconstructive Surgery Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1134134406
- ENUM-LEGACY 2006
- TAX-NARROW 2,421
- RX-LIGHT 137
- BOOK-THIN 278 in Texas
- PHOTO-ENUM James Wethe · 2006
Emily McLaughlin, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
137 ≥ 34th percentile 34% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Emily McLaughlin, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Emily McLaughlin, MD?
Quality data not reportedPrimary specialty
Plastic and Reconstructive Surgery Physician
Medicare Part D claims
137 49% vs specialty avg
Specialty distribution in Texas
How Plastic and Reconstructive Surgery Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Plastic and Reconstructive Surgery Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1134134406 |
|---|---|
| Specialty | Plastic and Reconstructive Surgery Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/29/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Emily McLaughlin, MD. Source: openpaymentsdata.cms.gov.
Total received
$516
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Emily McLaughlin, MD. To verify Emily McLaughlin, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
137
Total Claims
$719
Total Drug Cost
37
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 144.6
- Total Day Supply
- 1,504
- Generic Drug Cost
- $650
- Antibiotic Claims
- 23
Patient Demographics
- Average Patient Age
- 70.6 years
- Avg HCC Risk Score
- 0.80
- Gender Split
- 100% female / 0% male
- Age Distribution
- <65: 0, 65-74: 32, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Emily McLaughlin, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ondansetron Odt
Ondansetron Odt
26 claims
- Gabapentin
Gabapentin
23 claims
- Ibuprofen
Ibuprofen
18 claims
- Celecoxib
Celecoxib
17 claims
- Doxycycline Hyclate
Doxycycline Hyclate
12 claims
- Montelukast Sodium
Montelukast Sodium
12 claims
| Drug | Claims |
|---|---|
| Ondansetron Odt Ondansetron | 26 |
| Gabapentin | 23 |
| Ibuprofen | 18 |
| Celecoxib | 17 |
| Doxycycline Hyclate | 12 |
| Montelukast Sodium | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Plastic and Reconstructive Surgery Physician in TX →
All providers in Texas →
Compare specialties →
Plastic and Reconstructive Surgery Physician Overview
How Emily McLaughlin, MD fits within the Plastic and Reconstructive Surgery Physician landscape nationally.
2,421
Plastic and Reconstructive Surgery Physician Providers in US
54
States with Plastic and Reconstructive Surgery Physician
92
Avg Claims per Provider
Emily McLaughlin, MD's 137 claims are above the specialty average of 92.
Nationwide Plastic and Reconstructive Surgery Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for McLaughlin, both outside Texas so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Plastic and Reconstructive Surgery Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as McLaughlin.
One of 278 Plastic and Reconstructive Surgery Physician providers enrolled in Texas, 5 are shown here.
Dr. Ali Abtahi
D.O.
Plano, TX
Dr. Jaime Aburto
M.D.
El Paso, TX
Dr. Francisco Agullo
MD
El Paso, TX
Dr. Dare Ajibade
MD/PHD/MPH
Houston, TX
Dr. Mais Al-Karmi
MD
Galveston, TX
Compare Plastic and Reconstructive Surgery Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Emily McLaughlin, MD's specialty? ▼
Emily McLaughlin, MD specializes in Plastic and Reconstructive Surgery Physician and practices in Fort Worth, Texas. Credentials: MD.
How much does Emily McLaughlin, MD prescribe under Medicare Part D? ▼
In 2024, Emily McLaughlin, MD wrote 137 Medicare Part D claims totaling $719 in drug costs for 37 beneficiaries.
Where is Emily McLaughlin, MD located? ▼
Emily McLaughlin, MD is located at 1200 W. MAGNOLIA AVE, Fort Worth, TX, 76104. Phone: (817) 870-4833.
What is Emily McLaughlin, MD's NPI number? ▼
Emily McLaughlin, MD's National Provider Identifier (NPI) is 1134134406, issued on 07/29/2006.
How many Plastic and Reconstructive Surgery Physician providers are there in the US? ▼
There are 2,421 Plastic and Reconstructive Surgery Physician providers across 54 states in the US. The average Plastic and Reconstructive Surgery Physician provider writes 92 Medicare Part D claims per year.
What drugs does Emily McLaughlin, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Emily McLaughlin, MD's most frequently prescribed drugs include Ondansetron Odt, Gabapentin, Ibuprofen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Emily McLaughlin, MD accept Medicare? ▼
Emily McLaughlin, MD appears in CMS Medicare data with 137 Part D claims and 37 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Emily McLaughlin, MD's credentials? ▼
Emily McLaughlin, MD's NPI is 1134134406 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.